Entia Biosciences, Inc. (ERGO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 2, 2025
Theseus Pharmaceuticals Market Cap
Entia Biosciences has a market cap or net worth of $3.41 thousand as of August 6, 2025. Its market cap has decreased by -98.96% in one year.
Market Cap
3.41K
Enterprise Value
n/a
Revenue
265.47K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 18, 2008, Entia Biosciences's market cap has decreased from 3.26M to 3.41K, a decrease of -99.90%. That is a compound annual growth rate of -32.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 3.41K | -50.00% |
| Dec 13, 2024 | 6.81K | - |
| Dec 27, 2022 | 6.81K | -86.67% |
| Dec 31, 2021 | 51.09K | -88.81% |
| Dec 30, 2020 | 456.42K | -10.67% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 532.81M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.31M |
| CytoDyn | 347.26M |
| American Oncology Network | 330.70M |